U.S. patent number 3,740,143 [Application Number 05/085,353] was granted by the patent office on 1973-06-19 for automatic apparatus for determining the percentage population of particulates in a medium.
This patent grant is currently assigned to Technicon Instruments Corporation. Invention is credited to Warren Groner, Jacob Kusnetz, Alexander M. Saunders.
United States Patent |
3,740,143 |
Groner , et al. |
June 19, 1973 |
AUTOMATIC APPARATUS FOR DETERMINING THE PERCENTAGE POPULATION OF
PARTICULATES IN A MEDIUM
Abstract
New and improved automatic method and apparatus for
differentiating and determining the respective populations of
specific particulates in a medium, for example, leukocytes in a
whole blood sample comprises means for treating a number of phased
quotient streams, each containing a portion of such blood sample,
so as to stain either a specific type or a specific class of
leukocytes, and passing each quotient stream through a
corresponding viewing chamber. The number of stained leukocytes to
the number of both stained and unstained leukocytes in each sample
portion passing through the corresponding viewing chamber are
counted concurrently by photometric means, the ratio of such
numbers indicating the population of such specific leukocytes or
such specific class of leukocytes in the corresponding sample
portion. Preferably, the counting of both stained and unstained
leukocytes in the sample portions in the different quotient streams
are counted to a same predetermined reference, whereby the
respective populations of the specific types or specific classes of
leukocytes are directly related and recorded in correlated fashion,
and any variations in either the flow rate or the volume of the
sample portions in the different quotient streams are only
incidental. Also, when particular leukocytes of a same quotient
stream are stained and counted as a class, comparison-type logical
operations determine the respective populations of the individual
leukocytes in such class.
Inventors: |
Groner; Warren (Whitestone,
NY), Kusnetz; Jacob (Tarrytown, NY), Saunders; Alexander
M. (Bedford Village, NY) |
Assignee: |
Technicon Instruments
Corporation (Tarrytown, NY)
|
Family
ID: |
22191047 |
Appl.
No.: |
05/085,353 |
Filed: |
October 30, 1970 |
Current U.S.
Class: |
356/39; 356/411;
250/565 |
Current CPC
Class: |
G01N
1/312 (20130101); G01N 1/31 (20130101); G01N
15/1459 (20130101); G01N 2015/008 (20130101) |
Current International
Class: |
G01N
1/31 (20060101); G01N 1/30 (20060101); G01N
15/14 (20060101); G01n 033/16 (); G01j
003/46 () |
Field of
Search: |
;356/39,102-104,208
;250/222PC ;235/92CP,92PC |
References Cited
[Referenced By]
U.S. Patent Documents
Other References
"A Photoelectronic Instrument for Counting and Sizing Aerosol
Particles" British Journal of Applied Physics, Suppl. Vol. 3, 1954
S138-S143 .
"The Shape of Ground Petroleum Coke Particles," British Journal of
Applied Physics, Suppl. Vol. 3 pp. 516-581. .
"Cell Sizing: A Light Scattering Photometer For Rapid Volume
Determination" 40 Review Sc. Instruments pp. 1029-1032 August 1969.
.
"Instrumentation for Automated Examination of Cellular Specimens"
57 Proc. of the IEEE pp. 2007-2016. .
"Cell Volume Distribution Pattern Analysis" 54 Amer. Journal Clin.
Pathol. August 1970, J. L. Ladinsky. .
"Scanning Laser Microscope" 223 Nature August 1969, Davidouits et
al. .
"Rapid and Reliable Differential Counts on Dilute Leukocyte
Suspension" 76 Journal Lab. Clin. Med. 3 Sept. 1970, Oberjat et al.
.
Lillie, R. D., Histopathologic Technic & Practical
Histochemistry, Blakiston Div., McGraw-Hill, N.Y., 3rd Ed. .
Hewlett-Packard Catalogue, 1967, pp. 494-498..
|
Primary Examiner: Wibert; Ronald L.
Assistant Examiner: Clark; Conrad
Claims
What is claimed is:
1. Apparatus for determining the percentage population of a
selected type of particulate within a group of particulates
contained in a sample comprising
means for treating said sample to alter the characteristics of a
selected type of particulate,
means for viewing at least a portion of said treated sample,
first means responsive to said viewing means for counting a
predetermined number of particulates in said treated sample portion
having either altered or unaltered characteristics to define a
reference within which to count the population of said selected
particulates,
second means responsive to said viewing means for discriminating
said selected particulates on the basis of said altered
characteristics and for counting said selected particulates in said
treated sample portion within said reference, and
means for relating the respective counts of said first and second
counting means for determining the percentage population of said
selected particulates in said sample.
2. Apparatus as claimed in claim 1 wherein said sample is a liquid
containing a suspension of particulates, and further including
means for passing said treated liquid sample as a stream along a
viewing chamber,
said treating means being operative to alter the spectral
characteristics of said selected particulates,
said viewing means including means for directing a transverse light
beam through said viewing chamber,
said first and second means being responsive to said light beam
directed through said viewing chamber to count said particulates
having altered or unaltered characteristics and to count said
particulates having altered characteristics, respectively, while
passing along said viewing chamber.
3. Apparatus as claimed in claim 2 wherein said first means
includes means for detecting the passage along said viewing chamber
of said particulates having altered or unaltered spectral
characteristics with respect to a characteristic common to said
altered and unaltered particulates, and said second means includes
means for detecting the passage along said viewing chamber of said
selected particulates with respect to their altered spectral
characteristics.
4. Apparatus according to claim 2 wherein said first and second
means are operative with respect to particulates being passed
through a same portion of said viewing chamber, said first and
second means being operative concurrently to count particulates
having altered or unaltered characteristics and to count said
particulates having altered characteristics, respectively.
5. Apparatus according to claim 4 wherein said first means is
limited at a predetermined count and further including means for
inhibiting said second means when said predetermined count has been
attained by said first means, whereby the count attained by said
second means indicates the population of said selected particulate
within said predetermined count.
6. Apparatus as claimed in claim 3, wherein,
said first and second means, include first and second generating
means, respectively, to provide an indication upon the detection of
a particulate passing along said viewing chamber,
first and second counter means for counting indications provided by
said first and second generating means, respectively, said second
counter means being operative to count indications provided by said
second generating means only on the coincidence of an indication
being provided to said first counter by said first generating
means.
7. Apparatus according to claim 2 further including pressure means
for passing said liquid through said viewing chamber, said pressure
means including a high flow-resistance coil in fluid flow
communication with said viewing chamber and said pressure
means.
8. Apparatus as claimed in claim 1, wherein said medium is a liquid
sample containing a suspension of particulates,
means for passing said liquid sample as a stream, said passing
means including further means for dividing said liquid sample into
a plurality of quotient streams, said treating means being
operative to treat each of said quotient streams on an individual
basis for altering the characteristics of a different selected type
of particulates in each of said quotient streams and while
retaining the respective characteristics of other particulates in
each of said quotient streams substantially unaltered, said viewing
means being operative to view at least a portion of each of said
treated quotient streams,
said first means being operative to detect and count particulates
in each of said quotient streams having either altered or unaltered
characteristics to define a reference corresponding to said each
quotient stream,
said second means being operative to discriminate said selected
particulates in said each of said quotient streams on the basis of
said altered characteristics and to count said selected
particulates in said each quotient stream within said corresponding
reference, and
means for relating the respective counts of said first and second
means corresponding to said each quotient stream for determining
the percentage populations of said selected particulates in said
liquid sample, said defined references for each of said quotient
streams being related, whereby the respective percentage
populations of each of said selected particulates in said lIquid
sample are related.
9. An apparatus for determining the percentage population of a
selected type of leukocyte in a blood sample, comprising
means for treating a blood sample to selectively stain, at least, a
selected type of leukocyte therein,
means for viewing at least a portion of said treated sample to
discriminate and detect stained leukocytes and, also, to detect
stained and unstained leukocytes in said portion,
first means responsive to said viewing means for counting said
detected stained leukocytes in said portion of said blood sample to
provide a first count,
second means responsive to said viewing means for counting each of
said detected stained and unstained leukocytes in portion of said
blood sample to provide a second count, the ratio of said first and
second counts being indicative to the percentage population of said
selected type of leukocyte in said blood sample.
10. Apparatus according to claim 9, wherein said second counting
means is limited at a predetermined number, and further including
means responsive to said second counting means for inhibiting said
first counting means when said predetermined number has been
counted by said second counting means.
11. Apparatus according to claim 9, further including means for
operating said first counting means only in concurrence with the
operation of said second counting means.
12. Apparatus according to claim 9, further including means for
passing said treated blood sample as a flowing stream through a
viewing chamber, and said viewing means including optical means
associated with said viewing chamber for discriminating and
detecting said stained leukocytes and for detecting stained and
unstained leukocytes passing in said flowing stream along at least
a portion of said viewing chamber, said first and second counting
means being responsive to said optical means, said optical means
including means for passing light transversely through said portion
of said viewing chamber ; first means for detecting absorption of
said light beam to indicate passage of said stained leukocytes
along said portion of said viewing chamber; and second means for
detecting scattering of said light beam to indicate passage of
stained and unstained leukocytes along said portion of said viewing
chamber, said first and second counting means being responsive to
said first and second detecting means, respectively.
13. Apparatus for determining the respective percentage populations
of selected leukocytes in whole blood samples, comprising,
means for passing successive blood samples as a continuous
stream
means for dividing said continuous stream into a plurality of
quotient streams, each of said quotient streams including portions
of each of said successive samples,
means for treating each of said quotient streams to detectably
alter the characteristics of different selected ones of said
leukocytes in said quotient streams,
means for viewing at least a portion of each of said treated
quotient streams,
said viewing means including first means for discriminating and
counting selected leukocytes on the basis of said altered
characteristics in each of said sample portions contained in said
quotient streams, so as to provide a first count for each sample
portion,
said viewing means further including second means for detecting and
counting leukocytes having altered and unaltered characteristics in
each of said sample portions contained in said quotient streams, so
as to provide a second count for each sample portion, the ratio of
said first and second counts corresponding to a sample portion in
said quotient streams indicating the respective percentage
population of said selected leukocytes in the original blood,
and
means for correlating the respective percentage populations of said
selected leukocytes in said corresponding portions of said original
blood sample.
14. Apparatus according to claim 13, further including means for
separating said portions of each of said successive samples along
said quotient streams by an inert fluid segment.
15. Apparatus according to claim 13, wherein said treating means
includes means for detectably altering the characteristics of
leukocytes in a selected class of leukocytes in at least one of
said quotient streams.
16. Apparatus according to claim 15, wherein said first means are
operative to discriminate and count individual leukocytes in said
selected class in said one quotient stream on the basis of said
altered characteristics, so as to provide a third count, the ratio
of said third count and said second count provided by said second
means indicating the percentage population of said selected class
of leukocytes in said original blood sample.
17. Apparatus according to claim 16, wherein particular ones of
said leukocytes in said selected class have been treated in another
of said quotient streams, and further including means for
substracting the percentage population of said particular
leukocytes from the percentage population of said selected class of
leukocytes, so as to indicate the percentage population in said
original blood sample of remaining leukocytes in said selected
class.
18. Apparatus according to claim 13, wherein said second means, as
associated with at least one of said quotient streams, includes
means for discriminating and counting particular leukocytes in said
one stream on the basis of an unaltered characteristic of said
particular leukocytes.
19. Apparatus according to claim 17, wherein said treating means
are operative to stain so as to change the spectral characteristics
of a class of leukocytes along at least one quotient stream, while
leaving remaining leukocytes in said one quotient stream
substantially unchanged, and further including
means for passing said one quotient stream along a viewing chamber
having an unobstructed light passageway,
means for passing light along said passageway,
said first means being responsive to an absorption of said light
beam by each of said leukocytes having changed spectral
characteristics and said second means being responsive to a
scattering of light by said stained and unstained leukocytes, the
scattering of light being a direct function of the cellular size of
a leukocyte, and
third means responsive to said second means for discriminating and
identifying particular unstained ones of said leukocytes in said
class according to the magnitude of the scattered light signal.
20. Apparatus according to claim 19, further including means
responsive to said third means for counting said particular
unstained leukocytes, the ratio of the respective counts of said
third means and said second means associated with said one quotient
stream being indicative of the percentage population of said
particular unstained leukocyte in said original blood sample.
21. Apparatus according to claim 20, further including gating means
connecting said second means responsive to a scattering of light
and said third means for counting said particular unstained
leukocytes, said gating means being inhibitive by said first means
during detection of a stained leukocyte by said first means.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to apparatus and method for differentiating
the various types of leukocytes, or white cells, in whole blood
samples and, more particularly, to the precise determination of the
respective populations of the various types of leukocytes present
in whole blood samples by automatic and continuous techniques.
2. Description of the Prior Art
The information represented by the respective populations of
various types of leukocytes, or white cells, in the human blood
provides a sound basis for diagnostic processes. It has been
appreciated that each of the various types of leukocytes serves a
different and particular function within the human body, and that
the respective populations of the various types of leukocytes
provides valuable information regarding particular disease
processes, either infectious, inflammatory, immune, or
neoplastic.
Generally, three distinct types of formed bodies are present in the
whole blood, that is, erythrocytes or red blood cells, leukocytes
or white blood cells, and thrombocytes or platelets. Various
techniques have been developed in the prior art for differentiating
and counted the various types of leukocytes present in a whole
blood sample. Generally, such differentiation and counting is
performed manually by a skilled technician, and is effected by
visually examining a dried stained smear of human blood which has
been dried on a glass slide. Such techniques have been described,
for example, in Laboratory Medicine-Hemotology, (3rd ed.) by J. B.
Miale (The C. V. Mosby Company, St. Louis, Mo., 1967). In the
staining process, cytoplasm surrounding the nucleus of the
leukocytes and the nucleus proper are differentially stained, so as
to provide spectral and morphological information. Generally,
leukocytes are divided into two groupings, which are identified as
granulocytes and agranulocytes, respectively. The granulocytes are
identifiable as having granules in the cytoplasm which are somewhat
selectively sensitive to particular chemical stains. The
agranulocytes are those leukocytes with a relatively clear
cytoplasm, wherein comparatively few granules are found.
Accordingly, agranulocytes are less well differentiated from one
another by staining techniques but, however, agranulocytes can be
differentiated by their morphological properties.
The prior art manual techniques for differentiating and counting
leukocytes in a blood sample are overly cumbersome and tedious.
Generally, a technician manually smears a very small volume of
blood sample onto a clean glass slide. The smeared blood sample is
allowed to dry, and is subsequently treated with appropriate
staining chemicals and fixatives, e.g. Wrights stain. The product
is then examined under a microscope, the types of leukocytes being
individually differentiated and counted by the technician as they
are brought within the viewing field. The technique is tedious, and
subject to human error. Also, only a very small number of
leukocytes are examined, usually not over 100, and the
sub-classification or differentiation of the various types of
leukocytes is based on this small count, whereby only a very crude
approximation of their respective populations can be obtained.
Recent advances made in the technology have essentially extended
the visual technique by substituting an electronic interface,
including appropriate scanning and measuring devices, between the
viewing field of the microscope and a computer. These techniques
can be described, generically, as pattern recognition techniques,
whereby multiple parameters, or vectors, of the individual
leukocytes brought within the viewing field are measured. The
computer performs a series of calculations based on these multiple
parameters to identify and classify the particular type of
leukocyte. Notwithstanding its precision, accurate pattern
recognition techniques are comparatively slow, since the stained
blood sample is scanned in a particular pattern, either manually or
mechanically, and re-focusing by the technician often necessary
before a particular leukocyte can be measured accurately.
Admittedly, re-focusing and scanning of the slide may be effected
automatically, but such automation would be extremely expensive.
Without such automation, however, the system has no particular
advantages, since the counting rate is limited due to the scanning
and re-focusing processes. For example, in present-day pattern
recognition equipments, a skilled technician can process leukocytes
at the rate of about ten cells per minute. Accordingly, the large
count necessary to provide a sound statistical basis for a
meaningful measurement of the respective populations of the various
type of leukocytes in a blood sample is prohibitively expensive and
very time consuming.
Also, in the prior art, the differentiation of leukocytes has been
effected by passing a blood sample along an optical or electronic
system while suspended in either an aqueous or non-aqueous liquid.
However, when such systems have employed staining techniques, these
techniques have not been selective with respect to the individual
types of leukocytes and, therefore, such systems are operative only
to provide a total count, rather than a true differentiation and
sub-classification, of the various types of leukocytes, or
alternatively have based a differentiation of the leukocytes only
on their morphological properties.
Regardless of the techniques used in the prior art, an accurate
differentiation of various types of leukocytes in a blood sample
along with a sound statistical basis for determining their
respective populations, was not possible, except by very elaborate
and complicated equipments. This invention appreciates that one of
the major shortcomings of the prior art has been that the automated
differentiation of the various types of leukocytes in a blood
sample has been based mainly on a single class of parameters of the
cell, i.e., morphological or spectral information. Moreover,
accurate differentiation has been made more complicated since the
common practice had been to identify each of the different types of
leukocytes in a blood sample concurrently and each cell in
serial-like fashion, since a single volume of sample has been used,
which tends to increase significantly the possibility of error in
determining the respective population of the various types of
leukocytes.
OBJECTS OF THE INVENTION
Therefore, an object of this invention is to provide for an
improved method and apparatus for differentiating the various types
of leukocytes present in a blood sample.
Another object of this invention is to provide an automated method
and apparatus for the differentiation of leukocytes present in a
whole-blood sample and, also, to effect a subclassification of such
leukocytes.
Another object of this invention is to provide an automated method
and apparatus for concurrently determining the respective
populations of one or more types of leukocytes present in a blood
sample.
Another object of this invention is to provide a method and
apparatus for automatically screening a number of successive blood
samples, so as to determine the respective populations of various
types of leukocytes present in such samples.
Another object of this invention is to provide a method and
apparatus for differentiating and identifying particular types of
leukocytes in a blood sample by both spectral and morphological
information and in avoidance of human intervention.
Another object of this invention is to provide an automated method
and apparatus for determining, on a selective basis, the respective
population of a particular type of leukocyte present in a blood
sample.
Another object of the invention is to provide an automated method
and apparatus by which one or more types of leukocytes present in a
blood sample passing along a continuous-flow system can be
differentiated and their respective populations determined, on a
selective basis, and independently of the volume or flow rate of
such blood sample along such system.
Another object of the invention is to differentiate and determine
the population of a particulate in a liquid medium.
SUMMARY OF THE INVENTION
In accordance with the preferred embodiment of this invention, a
plurality of blood sample are introduced consecutively as a stream
into a continuous-flow system, similar to the type described in the
L. T. Skeggs et al. U.S. Pat. No. 3,421,432, issued on Mar. 22,
1966, which sample stream is divided into a plurality of quotient
streams. In each quotient stream, the erythrocytes are hemolyzed
and the leukocytes are fixed by introducing appropriate chemicals
into the individual quotient streams on a continuous basis, along
with staining chemicals selective with respect to a particular type
or class of leukocytes, whereby only that particular type or class
of leukocytes are stained in each quotient stream. The selective
staining of a particular type or class of leukocytes in each
quotient stream allows for a direct and very reliable enumeration
of the stained cells by automated means. Each type or class of
leukocytes can be identified by a single parameter, such that the
need for sensing multiple parameters and relating such parameters
to identify a particular type or class of leukocyte, such as in
pattern recognition techniques, is avoided.
In accordance with one feature of this invention, hereinafter
described as volume accounting, a same predetermined total number
of leukocytes, both stained and unstained, are counted in each of
the quotient streams, while concurrently identifying and counting
the number of stained leukocytes within that predetermined total
number or reference. The counting of the total number of stained
and unstained leukocytes and, also, the number of stained
leukocytes in the quotient streams is effected in parallel and in a
phased relationship, whereby the results can be correlated with
respect to a same blood sample. Accordingly, the volume as well as
the flow rate of the sample in each of the quotient streams are
incidental to and do not affect the ultimate percent count of the
stained leukocytes.
As hereinafter described, a particular type or class of leukocytes
in each quotient stream is selectively stained, such that the
presence of each stained leukocyte can be sensed by conventional
absorption techniques, and the counting of stained leukocytes in
the individual quotient streams can be effected concurrently and in
parallel fashion. Also, to relate the individual quotient streams,
the number of leukocytes, both stained and unstained, are
concurrently detected by conventional light scattering techniques
and counted. With respect to each particular quotient stream, the
scatter signals are counted independently and, during such
counting, the absorption signals are counted concurrently to
accumulate the count of the selectively stained leukocytes.
However, when the predetermined number of scatter signals have been
counted, further counting of the selectively stained leukocytes in
the particular quotient stream is inhibited. Accordingly, the
absorption signals, indicative of the selectively stained
leukocytes in the particular quotient stream, are only counted
during that time interval required for the counting of that
predetermined number of leukocytes, both stained and unstained,
passing through the viewing volume of a flow cell. However,
completion of the counting operation with respect to one quotient
stream does not inhibit the count operation with respect to the
remaining quotient streams. When the counting operations with
respect to each of the quotient streams have been completed, the
ratio of the counts of the scatter and absorption signals,
respectively, yields the percentage, or population, of the
particular type or class of leukocytes in the blood sample, which
can be recorded in correlated fashion. When a specific class of
leukocytes is counted, particular types of leukocytes in such class
can be differentiated by appropriate logical operations between the
parallel counting channels or by pulse-height discrimination
techniques within the corresponding channel, as described. Because
of the volume accounting, the system is substantially insensitive
to variations in the flow rate of the individual quotient streams
and, also, of the corresponding volumes of blood sample contained
in such quotient streams.
The scatter signal, according to other features of this invention,
serves a multiple function. For example, since the scatter signal
identifies the presence of a leukocyte, either stained or unstained
in the viewing volume of the flow cell, each scatter signal
identifies a valid sample period, and is used as a control signal
to operate the channel logic. As such, a more reliable statistical
base for determining the population of the leukocytes is achieved,
since the scatter signal can be used to sample the absorption
singal, whereby electrical noise is gated and reduced, as
described.
DESCRIPTION OF THE DRAWINGS
These and other objects and features of this invention will be made
clear by the following detailed description taken in conjunction
with the accompanying drawings wherein;
FIG. 1 is a plan showing the intended arrangement of FIGS. 1A, 1B
and 1C;
FIG. 1A is a schematic diagram of a continuous-flow
multiple-channel system wherein leukocytes in a whole blood sample
are stained on a selective basis;
FIGS. 1B and 1C are block diagrams illustrating logical systems for
counting the various types of leukocytes in the system shown in
FIG. 1A within a particular reference and for determining the
respective percentage populations of such leukocytes in the whole
blood sample. As shown, the logical systems of FIG. 1B are
operative with respect to the eosinophils, lymphocytes, and
neutrophils, whereas the logical systems of FIG. 1C are operative
with respect to the basophils and monocytes.
DETAILED DESCRIPTION OF THE INVENTION appropirate
Referring now to the drawings, the analytical system comprises a
sample device 1 for supplying individual blood samples in
succession along a conduit 3. Sample supply device 1 comprises an
indexible turntable 5 carrying a plurality of sample receptacles 7
arranged in a circular row. Turntable 5 is indexed intermittently
by appropriate drive means, not shown, to position sample
receptacles 7, in turn, at a takeoff position beneath an aspirating
probe 9. Aspirating probe 9 is controlled by appropirate mechanism
11, for example, as described in U.S. Pat. No. 3,134,263 issued on
May 26, 1964, to move into and out of a sample receptacle 7
positioned at the takeoff position during the dwell time of
turntable 5, whereby a portion of the sample is aspirated and
passed along conduit 3 for subsequent treatment and analysis, as
hereinafter described. Also, a wash reservoir 13 is positioned
adjacent turntable 5, and probe 9 is controlled by mechanism 11 to
be immersed in the wash reservoir during the indexing of the
turntable. Conduit 3 is connected in flow communication with each
of pump tubes 15, 17 and 19 in peristaltic pump 21, which are
continuously occluded by pump rollers, symbolically indicated at
23, against a platen 25. Accordingly, the stream directed along
conduit 3 comprises successive blood samples aspirated from
adjacent sample receptacles 7 and separated from each other by a
sequence of air, wash liquid, and air segments. Since conduit 3 is
connected to pump tubes 15, 17 and 19 by branching member 27, a
portion of each segment, whether gas or liquid, in the sample
stream is divided into a number of quotient streams, which are
directed into the various analytical channels for the selective
staining of leukocytes, as hereinafter described.
According to the preferred embodiment, the quotient stream passing
along pump tube 15 is treated for the staining and counting of
neutrophils and eosinophils, as a class, in analytical channel I
and, also, for the selective staining of eosinophils in analytical
channel II. The quotient stream along pump tube 15 is initially
mixed with a stream of an appropriate chemical for fixing the
leukocytes, e.g., formalin 10 percent in 0.2M sodium phosphate
buffer of approximately pH7.0, which is aspirated from a source,
not shown, along pump tube 29. The stream of fixative passing along
pump tube 29 is passed through an ice bath 31, e.g., at 4.degree. c
for approximately 5 minutes, and segmented by air passing along
pump tube 33, and joined into the quotient stream prior to passing
through mixing coil 35. The fixative stream is initially cooled, so
as to delay the chemical reaction which fixes the leukocytes until
a thorough mixing of the fixative and quotient streams has been
completed in mixing coil 35. The quotient stream passing from
mixing coil 35 through a heating coil 37, e.g., at 51.degree. for
approximately 3.5 minutes, to support and accelerate the fixing of
leukocytes. The fixed quotient stream from heating coil 37 passes,
in turn, through cooling coil 39, e.g., at 4.degree. c for
approximately 2 minutes, to inhibit further chemical reaction and
allow for the introduction of an appropriate lysing agent, e.g.,
acetic acid 10 percent in H.sub.2 O. The acetic acid is aspirated
from source, not shown, along pump tube 41, joined into the
quotient stream downstream of ice bath 39. When the acetic acid and
quotient streams have been joined, the resulting stream passed
through a heating bath 43, e.g., at 51.degree. c for 1.5 minutes,
such as to inactivate any catalase which might interfere with the
subsequent chemical reactions, e.g., the preferential utilization
of hydrogen peroxide, and, also, to complete the lysing of the
erothocytes, i.e., hemolysis, by the acetic acid present in the
quotient stream. The fixed and lysed quotient stream passes from
the heating bath 43 and is re-sampled along pump tubes 45 and 47,
so as to be passed as distinct quotient streams into analytical
channels AI and AII, respectively. The quotient stream passed along
pump tube 45 into analytical channel AI is initially mixed with an
appropriate substrate, for example, comprising hydrogen peroxide
and a solution of 4-chloro-1-naphthol, together with a solvent of
2.2'-dioxyethanol, buffered at a mildly acidic pH, of approximately
4.5, hereinafter referred to as dark dye, which are aspirated and
pumped along pump tube 49 and 51, respectively, from respective
sources, not shown, and mixed thoroughly while passing through
mixing coil 53. Preferably, to accelerate mixing, the dark dye
passed along pump tube 51 is segmented by a stream of air pumped
along pump tube 55. Preferably, the air along pump tube 55 which is
injected into the dark dye stream forms discrete air bubbles in
such stream, which occur at a frequency substantially greater than
the frequency of the inter-sample segmentation in the quotient
stream, so as to enter into the intra-sample segmentation of the
individual blood segments. As understood in the prior art,
intra-sample segmentation ensures thorough and complete mixing of
the different liquids while passing through mixing coils and, also,
that interior surface walls of the conduits along which a liquid
stream is passed are thoroughly scrubbed to prevent contamination
between the successive sample segments.
In analytical channel AI, the dark dye passing along pump tube 51
and appropriately segmented by air injected therein along pump tube
55 is joined with a stream of hydrogen peroxide (H.sub.2 O.sub.2)
passing along pump tube 49, so as to define the substrate. The
substrate stream is thoroughly mixed in mixing coil 53 and is
reactive to selectively stain both eosinophils and neutrophils as,
for example, described in the copending U.S. patent application of
H. R. Ansley et Ser. No. 85,333 filed on even date herewith. After
mixing in coil 53, the substrate is joined with the quotient stream
passing along pump tube 45, now fixed and lysed, and thoroughly
mixed while passing through mixing coil 57. The stream is then
passed through heating bath 59, e.g., at 37.degree. c, for
approximately 1.5 minutes, so as to accelerate the staining and
color the of he eosinophils and neutrophils. The color development
referred to is representing by the chemical equation:
4-chloro-1-naphthol+H.sub.2 O.sub.2 .sup.peroxidase H.sub.2 O+black
precipitate
Subsequent to color development the refractive index of the red
cell membranes is matched, e.g., by the addition of propylene
glycol, which is passed along pump tube 60 and joined into the
quotient stream and mixed therewith in mixing coil 61. The final
stream is then passed along mixing coil 61 and conduit 63 to the
flow cell arrangement 65, for the counting of the stained
leukocytes in the quotient stream, as hereinafter described.
A substantially similar procedure is followed in analytical channel
AII, with respect to the selective staining of the eosinophils in
the quotient stream passed along pump tube 47. As hereinafter
described, the actual count of the eosinophils is used to (1)
determine the particular percentage population of eosinophils in
the particular blood sample and (2) as a substraction factor to
determine their percentage population of neutrophils from the class
information obtained by the counting of the eosinophils and
neutrophils stained along analytical channel AI. In analytical
channel AII, the quotient stream passing along pump tube 47 is
mixed with a substrate, for example, comprising hydrogen peroxide
and a solution of 4-chlor-1-naphthol, together with a solvent of
2.2'-dioxi ethanol, buffered to an acidic pH of approximately 3.5,
hereinafter referred to as acid dye, passed along pump tubes 67 and
69, respectively. The stream of acid dye passed along pump tube 69
is segmented by air introduced along pump tube 71. Complete mixing
of the streams of acid dye and hydrogen peroxide to form the
substrate is ensured by passage through the mixing coil 73. The
substrate passing from mixing coil 73 and quotient stream passing
along pump tube 47 are joined and thoroughly mixed in mixing its 75
to effect the staining and color development of eosinophils in the
blood segment on a selective basis. Color development follows the
reaction in the above equation, except the pH is 3.5 room
temperature is used. Subsequent to color development the refractive
index of the red cell membranes is matched, e.g., by the addition
of propylene glycol, which is passed along pump tube 77 and joined
into the quotient stream and mixed therewith in mixing coil 79. The
quotient stream passing from mixing oil 79 and containing the
selectively stained eosinophils is directed along conduit 81 to its
corresponding flow cell arrangement 83.
The remaining analytical channels AIII and AIV of the system are
particularly adapted to selectively stain basophils and monocytes,
respectively. For example, and referring to analytical channel
AIII, the quotient stream passed along pump tube 17 is joined with
a stream containing appropriate staining and lysing agents, e.g.,
0.1 percent Neutral Red and 1 percent Saponin, buffered to
approximately a pH of 5.5, passed along pump tube 85 and which has
been previously segmented by air introduced along pump tube 87. The
resulting sample-dye stream is thoroughly mixed in mixing coil 89,
wherein dissolution of the erythorocytes is effected and staining
of the leukocytes is commenced. The quotient stream passing from
mixing coil 89 is joined with a stream of formalin passed along
pump tube 91 and subsequently passed along mixing coil 93, for
fixing the leukocytes in quotient stream. Subsequently, the
quotient stream passing from mixing coil 93 and containing
selectively stained basophils is joined with a stream of propylene
glycol passed along pump tube 95, for matching indices of
refraction within the quotient stream proper and passed along a
final mixing coil 97 and conduit 99 to its corresponding flow cell
arrangement 101. The described chemistry for selective staining of
basophils in the whole blood sample is commonly referred to as the
"Basophil Neutral-Red Method" and has been described at pages
1126-1127 of the above-identified book by John B. Miale, M.D.
The final leukocytes to be selectively stained are the monocytes,
which is effected in analytical channel AIV, for example, as also
described in the above-identified H. R. Ansley et al. patent
application. As illustrated, the quotient stream passed along pump
tube 19 is initially joined with a stream of fixative, e.g., 20
percent formalin buffered to approximate a pH of 6 with 0.1M
phosphate buffer, passed along pump tube 103, which has been
previously segmented by air introduced along pump tube 105. The
quotient and fixative streams are joined within a cooling bath 107,
e.g. at 4.degree. c, so as to inhibit all chemical reactions
between cells or plasma and the fixative until, at least, thorough
mixing is completed with mixing coil 109, also located in cooling
bath 107. The stream passing from cooling bath 107 is joined with a
substrate, e.g., .alpha.-napthol-butyrate, passed along pump tube
111 and mixed in mixing coil 113, wherein the leukocytes in the
quotient streams are fixed and the substrate is acted upon. The
fixed quotient stream passing from mixing coil 113 is joined with a
stream of coupling reagent, e.g., hexazonium pararosanilin, passed
along pump tube 115 and mixed within mixing coil 117, so as to
selectively stain and develop color in the monocytes in the
successive blood segments. The color is developed according to the
following equation:
a. .alpha.-naphthol butyrate .sup.lipase in monocyte naphthol
b. .alpha.-naphthol+hexazonium pararosanilin .fwdarw. colored
precipitate
The quotient stream passing from mixing coil 117 and containing
selectively stained monocytes is subsequently joined with a stream
of acetic acid passed along pump tube 119 for lysing the
erythrocytes. The lysing of erythrocytes is accelerated by passing
the quotient stream through mixing coil 121. Subsequently, the
quotient stream passing from mixing coil 121 and containing
selectively stained monocytes is joined with a stream of propylene
glycol passed along pump tube 123, so as to more closely match the
indices of refraction of the liquid stream and membranes of lysed
erythrocytes, and further mixed along mixing coil 125 before being
passed along conduit 127 to the corresponding flow cell arrangement
129.
The flow cell assemblies 65, 83, 101 and 129 associated with
analytical channels I, II, III and IV, respectively, are preferably
of the type shown and described in the above-identified patent
application of A. Elkind et al. Basically, in each flow cell
assembly, the quotient stream passed from the respective analytical
channel is entrained within a sheath stream of inert liquid and
coaxially confined by the latter, whereby the diameter of the
quotient stream can be very substantially reduced. Accordingly, the
leukocytes present in quotient stream, when passing through the
viewing chamber 151 of the flow cell assembly, are concentrated and
caused to flow in a more tandem fashion. Also, the provision of the
liquid sheath about the quotient stream avoids the possibility of
blockage of the viewing chamber by artifacts and other particulate
matter. Preferably, the quotient stream is confined to a diameter
of approximately 0.003 inches (75 microns), whereby coincidence of
leukocytes flowing through the viewing chamber 151 are very
substantially reduced; also, the diameter of the sheath stream is
in the order of 0.010 inches (250 microns) to allow for passage
through the corresponding viewing chamber 151 of any artifacts or
particulate matter.
In the drawings, the flow cell assemblies 65, 83, 101 and 129 and
associated photometric apparatus are identical in structure, and
the same references have been used to identify corresponding
structures. Each flow cell assembly has associated therewith
photometric equipment for detecting the passage of each stained
leukocyte by absorption techniques, for example, to effect the
counting of stained leukocytes passing along the viewing chamber
151, and, also, for detecting the passage of both stained and
unstained leukocytes passing along viewing chamber 151 by
scattering techniques. As hereinafter described, the scattered
signals are employed to effect the volume accounting techniques,
whereby the analytical results of each of the analytical channels
are positively related and, also, to provide appropriate control
signals for the logic arrangements hereinafter described.
Flow cell assemblies 65, 83, 101 and 129 each comprises a flow cell
153 as in flow communication with the corresponding conduit 63, 81,
99 and 127 along which the quotient stream, fully stained and
lysed, is passed from analytical channels I, II, III and IV,
respectively. Each conduit 63, 81, 99 and 127 includes a debubbling
structure which vents the conduit to atmosphere, whereby all
segmentizing air bubbles, both intra- and inter- sample, are
removed and only the remaining liquid constituents pass to the
corresponding flow cell 153 along conduit 157. Subsequent to
debubbling, the quotient stream along the conduit 157 comprises
adjacent blood samples separated only by a wash liquid segment, the
latter preventing contamination between successive samples flowing
to and along the flow cell 153. As illustrated, each quotient
stream is directed through a first tube inlet 157, whose outlet is
disposed concentrically with respect to viewing chamber 151 of the
flow cell. The sheath liquid for confining the quotient stream is
provided from a pressurized-bottle source 159, which is maintained
at a constant positive pressure by combined action of pump 161 and
pressure regulator 163. The output of the source 159 is connected
along a distributing conduit 165 to each of the flow cells 153
through an adjustable flow-control valve 167. The sheath liquid
passing through each flow-control valve 167 is introduced into the
corresponding flow cell 153 along a second tube inlet 169. Each
tube inlet 169 is positioned to introduce the sheath liquid, so as
to concentrically confine the quotient stream as it is caused to
flow through the viewing chamber 151, as described in the
above-identified Elkind et al. patent.
Since the hydraulic system associated with each analytical channel
AI, AII, AIII and AIV is opened by venting the quotient stream at
the debubbler structure 155, the quotient stream and the sheath
stream are pulled through the flow cell assembly 153 by a constant
negative pressure maintained within liquid-waste bottle 171 by the
combined action of vacuum pump 173 and vacuum regulator 175. As
illustrated, the output of each flow cell 153 is connected to waste
bottle 171 along a conduit 177. Each conduit 177 includes high
flow-resistance coils 179, which are temperature compensated in
heating bath 181 to stabilize the flow rate through the flow cell
assembly 153 against minor variations of flow resistance in the
hydraulic system and ensure that a constant flow rate is maintained
through the corresponding flow cell assemblies 153. The use of
temperature-compensated, high flow-resistance coils in
continuous-flow systems yas been more-fully described in the
co-pending deJong patent application.
Accordingly, each of the quotient streams which have been treated
in analytical channels AI, AII, AIII and AIV are passed through the
corresponding flow cell assemblies 153 in proper phase
relationship. While apparatus for independently adjusting the
relative phases of the quotient streams has not been illustrated,
such apparatus is known and has been described for example, in the
M. H. Pelavin U.S. Pat. No. 3,512,163, issued on May 12, 1970. The
leukocytes in the quotient streams passing along each viewing
chamber 151 are detected by scattering and absorption techniques
concurrently. Apparatus for the detection of such leukocytes by
scattering techniques and by absorption techniques have been
indicated schematically, since such apparatuses are well known in
the art and have been described in "Measurement of Small Particles
Using Light-Scattering. A Survey of the Current State of the Art"
by A. E. Martens, Ann. N. Y. Acad. Sci. 158: 690-702; in "Rapid
Multiple Mass Constituent Analysis of Biological Cells" by L. A.
Kamentsky et al., Ann. N. Y. Acad. Sci. 157: 310-323; and in
"Absorption Cytophotometry: Comparative Methodology for
Heterogeneous Objects, and the Two-Wavelength Method" by M. L.
Mendelsohn, which appears in "Introduction to Quantitative
Cytochemistry," edited by George L. Wied, Academic Press 1966, pp.
201-214. As shown, light from a source 183 is collimated by a
condenser lens arrangement 185 and directed through an aperture 189
defined in the aperture plate 187, so as to illuminate the
concentrically confined quotient stream passing along the viewing
chamber 151. The actual viewing volume wherein leukocytes are
detected is determined, essentially, by the diameter of the
quotient stream passing along viewing chamber 151 and the
dimensions of aperture 189. Preferably, the dimensions of aperture
189 in the direction of flow of the quotient stream should be
minimal, but related to the size of the cells to be measured and
the flow rate of the quotient stream so as not to occlude portions
of the cell or band-limit the response of either the scattering or
absorption apparatus; also, the dimensions of aperture 185
transverse to the direction of flow of the quotient stream should
encompass the entire diameter of the quotient stream and allow for
any variations or undulations in the flow pattern. The light beam
passing through the viewing chamber 151, therefore, is intercepted
by each of the individual leukocytes in the quotient stream, both
stained and unstained, and passed through a beam splitter 189. One
beam of light passing through beam splitter 189 passes through
aperture 191 defined in aperture mask 193 and is incident on a
photodiode 195, for measuring the absorption of the light beam by
each stained leukocyte. The second beam of light passing through
beam splitter 189 is directed toward photomultiplier tube 197,
which is discriminated by an aperture mask 199 having an annular
aperture 201, such that only portions of the light beam scattered
by the stained or unstained leukocytes in the quotient stream is
incident on photomultiplier 197.
The absorption and scattering signals generated by the photodiode
195 and photomultiplier 197, respectively, associated with each of
the analytical channels I, II, III, and IV are directed into
corresponding logic channels LI, LII, LIII, and LIV, whereby the
respective populations of the leukocytes in the various quotient
streams can be automatically determined and correlated with respect
to a same blood sample.
To facilitate an understanding of the logical operations for
particularly determining the respective populations of leukocytes,
reference is initially made to logic channels LII and LIV,
associated with analytical channels AII and AIV and adapted to
count the populations of eosinophils and monocytes, respectively. A
same basic logic arrangement is included in each of logic channels
LI and LIII, associated with analytical channels AI and AIII,
respectively, along with additional logic units. As hereinafter
described, logic channel LI is operative to determine the
population of neutrophils, which have been stained in a class
including eosinophils and the population of lymphocytes in the
blood sample, as hereinafter described. In the interest of
clarification, corresponding units in each of the logic channels LI
through LIV have been identified by a same reference.
Referring to the logic channels LII and LIV, associated with the
analytical channels AII and AIV, the scatter signals generated by
photomultiplier 197 upon passage of either stained or unstained
leukocytes through the viewing chamber 151 and the absorption
signals generated by photodiode 195 upon passage of stained
leukocytes through viewing chamber 151 are amplified by amplifiers
201 and 203, respectively. The outputs of amplifiers 201 and 203
are connected to the inputs of the comparator circuits 205 and 207
respectively, which are operated as thesholding devices, so as to
effectively block any noise present on the amplified scatter and
absorption signals, respectively. The output of the comparators 205
and 207 are connected, in turn, to the inputs of monostable
multivibrators 209 and 211, respectively. The output pulses
generated by multivibrators 209 and 211, respectively, correspond
in time to the presence of a stained leukocyte, in the viewing
chamber 151 of the corresponding flow cell 153; however, an output
pulse generated only by multivibrator 209 corresponds in time to
the presence of both a stained and an unstained leukocyte, in the
viewing chamber 151 of the flow cell 153.
As shown, the output of multivibrator 211 is connected to one input
of AND gate 213, whereas the output of multivibrator 209 is
connected to the remaining input of AND gate 213 and to one input
of AND gate 215, the output of AND gate 213 is connected to one
input of AND gate 217. The remaining inputs of both AND gates 215
and 217 are connected to the set output of flip-flop 219. As
hereinafter described, flip-flop 219 is set only when a previous
counting operation has been completed and recorded by the printer
221 and a next counting operation is to be initiated. To this end,
the set input of flip-flop 219 is connected to the output of AND
gate 223. One input of AND gate 223 is connected to printer 221
along lead 225. At the completion of each printing operation, as
hereinafter described, printer 221 energizes lead 225. The
remaining input of AND gate 223 is connected along lead 227 to the
output of adjustable time device 229. Timer 229 is responsive to
each indexing of turntable 5 to provide a control pulse along lead
227 which is delayed to coincide with the passage of the treated
quotient streams of the blood sample being aspirated through the
viewing chambers 151, respectively, associated with the various
analytical channels. In operation, timer device 229 provides a
series of control pulses which are in phase with the passage of the
successive blood samples in the flow cell assemblies 153.
Assuming that the results of a previous counting operation has been
printed by printer 221 and lead 225 has been energized, so as to
condition AND gate 223, a pulse provided by timer device 229 along
lead 227 energizes AND gate 223 which, in turn, sets flip-flop 219.
When flip-flop 219 has been set, each of the AND gates 215 and 217
is energized. The outputs of AND gates 215 and 217 are connected to
the inputs of preset counter 231 and accumulating counter 233,
respectively, which have been previously reset to zero by a reset
pulse directed along lead 235 by printer 221 at the completion of a
previous printing operation. As hereinafter described, AND gates
215 and 217 control the operations of preset counter 231 and
accumulating counter 233, respectively, such that the respective
populations of stained leukocytes stained in each of the quotient
streams and present in a same original blood sample can be properly
related and directly recorded.
Accordingly, the scatter pulses generated by multivibrator 209 in
the basic logic arrangement pass through AND gate 215 to preset
counter 231, whose count is indicative of the total number of
leukocytes, both stained and unstained, passed through viewing
chamber 151 of the associated flow cell 153 since the commencement
of a counting operation, i.e., the setting of flip-flop 223.
Concurrently, the absorption pulses generated by multivibrator 211
in the basic logic arrangement pass through AND gate 213 and AND
gate 217 to the accumulating counter 233, whose count is indicative
of the total number of stained leukocytes within the total count
indicated by preset counter 231. Accordingly, the percentage
population of the stained leukocytes being counted in any logic
channel is given immediately by the ratio of the respective counts
of preset counter 231 and accumulating counter 233. It can be
appreciated that the larger the count provided for on the preset
counter 231, the more accurate, on a statistical basis, is the
determination of the population of the particular leukocyte.
Due to the operation of AND gate 213, accumulating counter 233 is
operative to count an absorption pulse only where coincident with a
scatter pulse. In effect, AND gate 213 serves to sample the
absorption signal, so as to substantially reduce the possibility of
"false" counts due to random large noise signals appearing at the
output of absorption amplifier 203 and resulting, for example, from
the passage of artifacts through the associated viewing chamber 151
or noise developed within the amplifier passing to multivibrator
211, and having a magnitude in excess of the threshhold in
comparator 207. However, the occurrence of a large noise signal in
the absorption channel concurrently with the generation of a
scatter pulse by the multivibrator 209, due to the presence of an
unstained leukocyte in the viewing chamber 151, can be passed
through AND gates 213 and 217 and counted by accumulation counter
233. On a statistical basis, this is very remote possibility, and
the ratio of the respective counts in accumulating counter 233 and
preset counter 231 provides a very reliable indication of the
percentage population of the selectively stained leukocytes in the
corresponding analytical channel. Preferably, preset counter 231 is
limited at a predetermined count, for example, 10,000 or any other
multiple of 100, whereas accumulating counter 233 is not so
limited. When preset counter 231 has completed its count, for
example, to 10,000, it inhibits further counting by the
corresponding accumulating counter 233, and is operative to supply
a control pulse along lead 237 to the reset input of flip-flop 219.
Resetting of flip-flop 219 operates to inhibit AND gates 215 and
217 and to prevent any further counting of scatter and absorption
pulses by preset counter 231 and accumulating counter 233,
respectively. The output of preset counter 231 is also connected
along lead 237 to a corresponding input of the start-scan AND gate
239, which initiates the operation of multiplexer unit 241, as
hereinafter described. Each of the remaining inputs of start-scan
AND gate 239 are connected to appropriate units in corresponding
logic channels, wherein an indication is provided that all logic
and counting operations in that particular channel have been
completed and that information is available for the printer 221.
Start-scan AND gate 239, therefore, operates to delay recording of
information accumulated in each of logic channels LI, LII, LIII and
LIV, until the logic and counting operations in all such channels
have been completed with respect to a particular blood sample,
whereby such information can be correlated and recorded with
respect to the particular blood sample and, hence, with the
corresponding source individual.
If desired, the machine function of each logic channel can be
monitored by a rate monitor 243 and a stylus recorder 245. The
input of rate monitor 243 is connected to the output of
multivibrator 209, and the output of rate monitor 243 connected to
stylus-drive mechanism of stylus recorder 245. Rate monitor 243
operates to integrate scatter pulses generated by multivibrator
209, and controls the deflection of the stylus. The deflection of
the stylus in recorder 245 provides a continuous indication of the
concentration of leukocytes passing through viewing chamber 151 of
flow cell 153. The leukocyte concentration in each viewing chamber
151 varies due to the presence of a wash liquid segment between
successive blood samples in the quotient stream, since air segments
have been debubbled and, also, due to some intermixing between the
wash liquid segment and the contiguous blood samples. While a blood
sample of constant dilution is passing through the viewing chamber
151 of the corresponding flow cell arrangement 153, the stylus
deflection, or trace, is essentially flat, so as to indicate a
steady-state condition. Also, the control pulse generated by the
timer device 229 is connected to rate monitor 243 along lead 227
and loads the rate monitor, so as to superimpose a blip on the
trace, provided on the stylus recorder which indicates the
commencement of a counting operation, and concurrently sets
flip-flop 223, whereupon the scatter and absorption pulses are
passed to preset and accumulating counters 231 and 233
respectively. If such blip does not coincide with the plateau of
the trace, it is indicative that the counting operation is not
properly phased with respect to the passage of blood sample in the
quotient stream through the corresponding analytical channel and
through the corresponding flow cell arrangement 153. In such event,
the phasing, or running time, of the quotient streams to the
corresponding flow cells 153 can be adjusted individually by
structures known in the art and, for example, described in the
above-identified M. H. Pelavin U.S. patent.
The logic operations hereinabove described are applicable where a
single leukocyte is stained in a particular analytical channel and
its respective percentage population is to be determined. The logic
channels LII and LIV are adapted to determine the respective
percentage populations of eosinophils and monocytes, respectively,
within the total counts of the corresponding preset counters 231.
When the counting operation in each logic channel has been
completed, the particular count of the stained leukocytes remains
in the corresponding accumulating counter 233, and is available for
recording. Each logic channel is inhibited by the action of the
corresponding preset counter 231 in resetting flip-flop 219,
whereby the blocking AND gates 215 and 217 are disabled.
The same basic logic arrangement, as described, is included in each
of logic channels AI and AIII. In logic channel AI, however,
additional logic circuitry is provided (1) for selectively
discriminating the neutrophils from the total count of neutrophils
and eosinophils, which have been selectively stained as a class in
analytical channel LI and counted as a class in the corresponding
accumulating register 233 and (2) for counting lymphocytes, which
have not been stained in the analytical channel LI, by their size
as manifested by scatter pulse-height discrimination. In logic
channel III, additional logic circuitry is provided to selectively
and positively spectrally discriminate the basophils, which have
been selectively stained in analytical channel III, from noise
signals, which have no particular spectral signature. In each of
logic channel LI and LIII, those units included in the basic logic
arrangement, as described, are identified by a same reference
number.
Referring to logic arrangement LI, and in accordance with the above
described, the absorption pulses are generated by multivibrator 211
upon passage of either an eosinophil or a neutrophil along the
viewing chamber 151 of corresponding analytical channel AI.
Accordingly, the count in accumulating counter 233 identifies the
total population of these leukocytes within the count of preset
counter 231 of logic arrangement LI. As described above, the count
in accumulating counter 233 of logic channel LII identified the
total count of eosinophils within the count of the corresponding
preset register 231 in the segment of the same blood sample passed
along analytical channel LII. The preset counters 231 in logic
channels LI and LII are limited at a same count. As shown, the
respective outputs of the accumulation registers 233 in logic
channels LI and LII are connected to inputs of a subtract register
247. Subtract register 247 is connected to the output of AND gate
249, whose inputs are connected to leads 237 from preset counters
231 in logic channels LI and LII, respectively. Accordingly, when a
counting operation has been completed in each of logic channels LI
and LII, AND gate 249 is enabled to trigger subtract register 247.
Subtract register 247 operates to subtract the eosinophil count in
accumulating counter 233 of logic channel LII from the total
eosinophil-neutrophil count in accumulating counter 233 of logic
channel LI, the difference being stored and indicating the total
neutrophil count in the particular blood sample. When the subtract
operation is completed, subtract register 247 energizes one input
of AND gate 251, whose other input has been previously energized by
preset counter 231 in logic channel LI along lead 253. Energization
of AND gate 251 indicates that logic arrangements LI and LII and
subtract register 247 have completed their respective operations.
AND gate 251, in turn, energies a corresponding input of start-scan
AND gate 239. Since preset counters 231 in logic arrangements LI
and LII, respectively, have been limited to a same count, the total
eosinophil count in accumulation counter 233 of logic channel LII
and the tOtal neutrophil count in subtract register 247 are
properly related with respect to the same blood sample.
Additionally, logic arrangement LI includes additional logic to
determine the percentage population of lymphocytes in the blood
sample by pulse-height discrimination techniques. As lymphocytes
and monocytes are agranulocytes, they are not stained, as are the
eosinophils and neutrophils, in analytical channel AI. However,
lymphocytes are readily discriminated with respect to monocytes by
the marked differences in the respective sizes of their cellular
structures. Normally, a lymphocyte has a much smaller diameter,
e.g. up to approximately 7 microns, than the diameter of a monocyte
which ranges from 12 and 20 microns. Since the quantity of light
scattered by a cellular structure is an increasing function of
size, the presence of a lymphocyte in the viewing channel 151 of
analytical channel LI can be detected and identified. To this end,
the output of scatter amplifier 201 in logic arrangement LI is
coupled to a second comparator 255 along lead 257. Comparator 255
provides an output only when the amplified scatter signal exceeds
that magnitude generated by a monocyte passing through viewing
chamber 151. The output of comparator 255 is connected along lead
259 to a multivibrator 261, whose output is connected to one input
S.sub.H of anti-coincidence gate 263. The outputs of scatter
multivibrator 209 and absorption multivibrator 211 in logic
arrangement LI are connected to second and third inputs S.sub.L and
A, respectively, of anti-coincidence gate 263. Since pulses applied
at inputs S.sub.L, S.sub.H and A of anti-coincidence gate 263 are
generated in response to the presence of the same leukocyte in
viewing chamber 151 of analytical channel AI, such pulses, if
generated, are coincident. Anti-coincident gate 263 is operative to
generate the function S.sub.L.sup.. S.sub.H.sup.. A. That is, the
absence of a signal at input A identifies the particular leukocyte
in viewing chamber 151 as not being stained and as being an
agranulocyte; the presence of a signal at input S.sub.H indicates
that a leukocyte present in the viewing chamber has a size in
excess of the normal size of a lymphocyte and, hence, a monocyte;
and the presence of a signal at input S.sub.L indicates the
presence of a leukocyte within the viewing chamber. Accordingly,
anti-coincidence gate 263 discriminates the passage of a lymphocyte
through viewing chamber 151 of analytical channel AI, according to
the above function.
The output of anti-coincidence gate 263 is connected to one input
of a second blocking AND gate 265, whose remaining input is
connected to the set output of flip-flop 219 a logic channel LI.
The output of blocking AND gate 265 is connected to the input of a
second accumulating counter 267, whose count is indicative of the
number of lymphocytes included within the total count indicated by
preset counter 231 in logic arrangement LI. The output of the
accumulating register 267 is connected to a corresponding terminal
of multiplexer 241. The operation of accumulating counter 267 is
similar to that of accumulating counter 233 in logic arrangement
LI, in that its operation is inhibited upon resetting of flip-flop
219 by printer 221, as described, and it is reset by a control
pulse passed along lead 235 by printer 221 upon completion of a
print-out operation. Also, since the count in the accumulating
register 267 is related to preset counter 231 of logic channel LI,
the operation of AND gate 251 to energize the corresponding input
of start-scan AND gate 239 indicates the availability of the
lymphocyte count.
With respect to the counting of basophils, which generally have a
population less than 1 percent of the total leukocyte population in
whole blood, logic arrangement LIII, as illustrated, is operative
to discriminate any artifact, e.g., dust particle, gas bubble,
etc., passing through the corresponding viewing chamber 151 and,
also, random electrical noise which could produce a false count and
materially affect the determination of the percentage population of
basophils in the blood sample. To this end, a dichroic mirror is
associated with beam splitter 189 in flow cell assembly 101, so as
to reflect the blue component of the absorption signal to a
photodiode 271 and to pass the red component to a photodiode 273.
Each of the photodiodes 271 and 273 is shielded by an aperture
plate 193, as described. In effect, logic channel LIII includes
parallel absorption channels for processing the red and blue
components, respectively, of the absorption signal. Since the
basophils are stained red, they are absorbing of blue light.
Accordingly, a stained basophil in viewing chamber 151 of
analytical channel AIII, substantially reduces the intensity of
light incident on photodiode 271; however, the presence of such
stained basophil does not substantially reduce the intensity of
light incident on photodiode 273. In the most general case,
therefore, the smallest amplitude signal generated in response to
the presence of a stained basophil in viewing chamber 151 of
analytical channel AI is produced at the output of the photodiode
273 during a counting sequence. Therefore, rather than provide
associative logic to discriminate such signals, logic channel LIII
counts basophils and any noise pulses, and, also, the noise pulses
individually, and subtracts such counts to provide the total
basophil percentage population in the particular blood sample.
As shown, the output of photodiode 273 is connected to amplifier
275, whose output signal is connected to the input of comparator
277. Comparator 277 compares the output signal of amplifier 275,
and provides an output only when the amplitude of such signal
exceeds that corresponding to the presence of a stained basophil in
viewing chamber 151. In effect, comparator 277 does not provide an
output in response to the presence of a basophil in viewing chamber
151; rather, the output of comparator 277 is indicative of a noise
signal which could be falsely counted as a basophil. The parallel
comparator 207, in the basic logic arrangement of logic channel
LIII, is connected to the output of photodiode 271 along amplifier
203, such comparator 207 operates, as described, to compare the
output signal of amplifier 207 and provide an output when such
signal exceeds a preestablished threshold. Accordingly, the output
of comparator 207 in logic channel LIII is indicative of either the
presence of a basophil in the viewing chamber 151 or of a noise
signal which could be falsely counted as a basophil. The outputs of
comparators 207 and 277 are connected to the inputs of
multivibrators 211 and 279, respectively. Accordingly,
multivibrator 211 generates an output pulse in response to each
basophil absorption and large noise signal, whereas the
multivibrator 279 generates an output pulse only in response to a
large noise signals. The outputs of multivibrators 211 and 279 are
connected to one input of AND gates 213 and 281, respectively; the
remaining inputs of AND gates 213 and 281 are connected to the
output of multivibrator 209 in logic channel LIII, so as to be
gated upon the coincidence of a scatter signal, as described. The
outputs of multivibrator 209 and AND gates 213 and 281 are
connected to one input of blocking AND gates 215, 217 and 283,
respectively, in logic channel LIII; the remaining inputs of
blocking AND gates 215, 217, and 283 are connected to the set
output of flip-flop 219. When flip-flop 219 is set and blocking AND
gates 215, 217, and 283 are enabled during a counting cycle,
scatter pulses generated by multivibrator 209 are counted in preset
counter 231, whereas accumulating counters 233 and 285 are
operative to count absorption pulses generated by multivibrator 211
and 279, respectively, in coincidence with such scatter pulses.
The outputs of accumulation registers 233 and 285 in logic channel
LIII are connected to respective inputs of a subtract register 287.
When the counting cycle in logic channel LIII is completed, as
indicated by a full count in preset counter 231, preset counter
operates to trigger subtract register 287 along lead 237-289, so as
to subtract the total counts in the accumulation registers 233 and
285, and store the difference indicative of the total number of
basophils in the total leukocyte count indicated by preset register
231 of logic channel LIII. When the subtract register has completed
its operation, it energizes one input of AND gate 291, whose other
input has been previously energized by the preset counter 231 of
logic channel LIII. The output of AND gate 291 is connected to one
input of start-scan AND gate 239, which input is energized to
indicate that the basophil count in logic channel LIII has been
completed.
At the completion of each counting operation, therefore, the total
lymphocyte count is stored in the accumulating counter 267 in logic
channel LI; the total neutrophil count is stored in subtract
register 247, which is responsive to the accumulating counters 233
in logic channels LI and LII, respectively; the total eosinophil
count is stored in accumulating counter 233 of logic channel LII;
the total basophil count is stored in the subtract register 287
responsive to accumulating counter 233 and 285 of logic channel
LIII; and the total monocyte count is stored in accumulating
counter 233 in logic channel LIV. The outputs of each of these
registers are connected to corresponding inputs of multiplexer 241,
as shown. The total percentage population of each respective cell
type is given by the ratio of its corresponding count to the count
indicated by its corresponding preset register 231. Advantageously,
the preset counters 231 in each of the logic channels LI, LII,
LIII, and LIV are limited to a same number, preferably, 10,000,
whereby the conversion to percentage population of the individual
cell types is given directly by the first-two significant digits of
the individual count contained in the corresponding accumulating
counter, and avoids the need for additional ratioing circuitry.
Multiplexer 241 is operative, at least, to readout he first-two
significant digits from each of the registers, preferably, on a
sequential basis. When the counting sequence has been completed,
each input of the start-scan AND gate 239 has been energized, and a
control pulse is directed along lead 293 to trigger multiplexer
241. The information from each of accumulating counter 267 in logic
channel LI (lymphocyte), subtract register 247 (neutrophil),
accumulating counter 233 in logic channel LII (eosinophil) subtract
register 287 (basophil), and accumulating register 233 in logic
channel LIV (monocyte), is directed, in turn, to printer 221.
Printer 221 permanently records the percentage populations of each
of the different cell types contained in a same blood sample and as
stored in these registers in correlated fashion. When multiplexer
241 has completed its scan and printer 221 has completed its
recording operation, printer 221 generates a control pulse, or
level, along lead 235 to reset each of the flip-flops 219 and
concurrently reset each of preset counters 231 and accumulating
counters 233 in logic channels LI, LII, LIII, and LIV, along with
the additional accumulating counters 267 and 285 in logic channels
LI and LIII, respectively. Accordingly, a next control pulse
directed along lead 227 indicating the presence of stained segments
of a next blood sample in the quotient streams passing through
viewing windows 151 of analytical channels AI, AII, AIII, and AIV,
respectively, operates to enable each of the AND gates 223 which,
in turn, set flip-flop 219 in each logical channel and commence a
next counting operation with respect to the next sample.
* * * * *